Drug Eluting Stents Des Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0062223
  • Format: Electronic (PDF)
  • Publish Type: Publish
  • Number of Pages: 250
Home Healthcare drug eluting stents des market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500
Report Description Table Of Content Research Methodology Download Free Sample

Market Snapshot

CAGR:9.42
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 9.42
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

Drug Eluting Stents (DES) Market Analysis Report 2023-2032

The Drug Eluting Stents (DES) Market is projected to experience a Compound Annual Growth Rate (CAGR) of 7.92% between 2022 and 2032. The market size is anticipated to witness an increase by USD 6,254.78 million during this period. The growth of this market is influenced by various factors, including the rising prevalence of cardiovascular diseases, advancements in medical technology, and the increasing demand for minimally invasive treatment options. Drug eluting stents are medical devices used to treat coronary artery disease by providing sustained drug release to prevent restenosis.

Drug Eluting Stents (DES) Market Overview

Drivers

One of the primary drivers propelling the growth of the Drug Eluting Stents (DES) Market is the increasing prevalence of cardiovascular diseases. Cardiovascular diseases, including coronary artery disease, remain a leading cause of mortality globally. Drug eluting stents have emerged as an effective treatment option, offering improved outcomes compared to traditional bare-metal stents by reducing the risk of restenosis.

Moreover, advancements in medical technology have led to the development of innovative drug eluting stents with enhanced biocompatibility, improved drug release kinetics, and reduced risk of adverse events. These technological innovations have expanded the application of DES, attracting both patients and healthcare providers.

Trends

A noteworthy trend shaping the Drug Eluting Stents (DES) Market is the integration of bioresorbable drug eluting stents. These stents gradually dissolve over time, leaving behind only the natural vessel structure. Bioresorbable stents eliminate the long-term presence of metallic stent scaffolds, potentially reducing the risk of late adverse events and allowing the vessel to restore its normal function.

Furthermore, the customization of drug eluting stents to cater to individual patient characteristics is gaining traction. Personalized treatment approaches involve selecting stents with specific drug coatings and designs based on patient factors, such as genetic predisposition and comorbidities.

Restraints

Despite the positive growth prospects, challenges exist in terms of reimbursement policies and the cost of advanced drug eluting stents. Ensuring affordable access to these medical devices remains a concern in some healthcare systems.

Drug Eluting Stents (DES) Market Segmentation By Application

The treatment of coronary artery disease is expected to be a significant growth segment in the Drug Eluting Stents (DES) Market. Coronary artery disease accounts for a substantial portion of cardiovascular diseases, and drug eluting stents have revolutionized its treatment by preventing restenosis and improving long-term outcomes.

Drug Eluting Stents (DES) Market Segmentation By Type

The durable polymer drug eluting stents segment is expected to witness significant growth during the forecast period. These stents incorporate polymer coatings to control drug release, maintaining drug efficacy over an extended period.

Regional Overview:


Download the report summary now!

Request pdf Sample

Regions with a high prevalence of cardiovascular diseases, such as North America and Europe, are expected to contribute significantly to the growth of the Drug Eluting Stents (DES) Market. The Asia-Pacific region is also witnessing an increasing demand for advanced treatment options due to changing lifestyles and a growing elderly population.

Drug Eluting Stents (DES) Market Customer Landscape

The Drug Eluting Stents (DES) Market report provides insights into patient preferences, healthcare provider perspectives, and factors influencing treatment decisions. Understanding patient needs and healthcare provider preferences is crucial for manufacturers to design products that align with market demands.

Major Drug Eluting Stents (DES) Market Companies

Companies in the Drug Eluting Stents (DES) Market are focusing on research and development to create stents with improved drug delivery profiles, reduced adverse events, and enhanced patient outcomes.

Sample list of major companies in the market:

  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Cook Medical Inc.
  • MicroPort Scientific Corporation
  • Biosensors International Group, Ltd.
  • Stentys SA
  • Elixir Medical Corporation

Qualitative and quantitative analyses of these companies provide insights into the competitive landscape, allowing stakeholders to understand market dynamics and assess the strengths and weaknesses of key players.

Segment Overview

The Drug Eluting Stents (DES) Market report offers revenue forecasts on a global, regional, and country level, along with an analysis of trends and growth opportunities from 2019 to 2032.

  • Application Outlook (USD Million, 2019 - 2032)
    • Coronary Artery Disease
    • Peripheral Artery Disease
    • Others
  • Type Outlook (USD Million, 2019 - 2032)
    • Durable Polymer Drug Eluting Stents
    • Bioresorbable Polymer Drug Eluting Stents
    • Other Types
  • Geography Outlook (USD Million, 2019 - 2032)
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • Japan
      • India
      • Rest of APAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa

Table of Contents

1 Study Coverage
1.1 Drug Eluting Stents (DES) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drug Eluting Stents (DES) Market Size Growth Rate by Product
1.4.2 Cobalt-chromium alloy Stents
1.4.3 Magnesium alloy Stents
1.4.4 Tyrosine polycarbonate Stents
1.4.5 Nitinol Stents
1.4.6 Platinum chromium alloy Stents
1.4.7 Stainless steel Stents
1.4.8 Other Materials
1.5 Market by End User
1.5.1 Global Drug Eluting Stents (DES) Market Size Growth Rate by End User
1.5.2 Coronary Heart Disease
1.5.3 Clinical
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drug Eluting Stents (DES) Market Size
2.1.1 Global Drug Eluting Stents (DES) Revenue 2014-2025
2.1.2 Global Drug Eluting Stents (DES) Sales 2014-2025
2.2 Drug Eluting Stents (DES) Growth Rate by Regions
2.2.1 Global Drug Eluting Stents (DES) Sales by Regions
2.2.2 Global Drug Eluting Stents (DES) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Drug Eluting Stents (DES) Sales by Manufacturers
3.1.1 Drug Eluting Stents (DES) Sales by Manufacturers
3.1.2 Drug Eluting Stents (DES) Sales Market Share by Manufacturers
3.1.3 Global Drug Eluting Stents (DES) Market Concentration Ratio (CR5 and HHI)
3.2 Drug Eluting Stents (DES) Revenue by Manufacturers
3.2.1 Drug Eluting Stents (DES) Revenue by Manufacturers (2014-2019)
3.2.2 Drug Eluting Stents (DES) Revenue Share by Manufacturers (2014-2019)
3.3 Drug Eluting Stents (DES) Price by Manufacturers
3.4 Drug Eluting Stents (DES) Manufacturing Base Distribution, Product Types
3.4.1 Drug Eluting Stents (DES) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug Eluting Stents (DES) Product Type
3.4.3 Date of International Manufacturers Enter into Drug Eluting Stents (DES) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Drug Eluting Stents (DES) Sales by Product
4.2 Global Drug Eluting Stents (DES) Revenue by Product
4.3 Drug Eluting Stents (DES) Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Drug Eluting Stents (DES) Breakdown Data by End User

6 North America
6.1 North America Drug Eluting Stents (DES) by Countries
6.1.1 North America Drug Eluting Stents (DES) Sales by Countries
6.1.2 North America Drug Eluting Stents (DES) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drug Eluting Stents (DES) by Product
6.3 North America Drug Eluting Stents (DES) by End User

7 Europe
7.1 Europe Drug Eluting Stents (DES) by Countries
7.1.1 Europe Drug Eluting Stents (DES) Sales by Countries
7.1.2 Europe Drug Eluting Stents (DES) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug Eluting Stents (DES) by Product
7.3 Europe Drug Eluting Stents (DES) by End User

8 Asia Pacific
8.1 Asia Pacific Drug Eluting Stents (DES) by Countries
8.1.1 Asia Pacific Drug Eluting Stents (DES) Sales by Countries
8.1.2 Asia Pacific Drug Eluting Stents (DES) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drug Eluting Stents (DES) by Product
8.3 Asia Pacific Drug Eluting Stents (DES) by End User

9 Central & South America
9.1 Central & South America Drug Eluting Stents (DES) by Countries
9.1.1 Central & South America Drug Eluting Stents (DES) Sales by Countries
9.1.2 Central & South America Drug Eluting Stents (DES) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drug Eluting Stents (DES) by Product
9.3 Central & South America Drug Eluting Stents (DES) by End User

10 Middle East and Africa
10.1 Middle East and Africa Drug Eluting Stents (DES) by Countries
10.1.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Countries
10.1.2 Middle East and Africa Drug Eluting Stents (DES) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drug Eluting Stents (DES) by Product
10.3 Middle East and Africa Drug Eluting Stents (DES) by End User

11 Company Profiles
11.1 Abbott Vascular
11.1.1 Abbott Vascular Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Vascular Drug Eluting Stents (DES) Products Offered
11.1.5 Abbott Vascular Recent Development
11.2 Advantec Vascular
11.2.1 Advantec Vascular Company Details
11.2.2 Company Business Overview
11.2.3 Advantec Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Advantec Vascular Drug Eluting Stents (DES) Products Offered
11.2.5 Advantec Vascular Recent Development
11.3 B.Braun Melsengen AG
11.3.1 B.Braun Melsengen AG Company Details
11.3.2 Company Business Overview
11.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 B.Braun Melsengen AG Drug Eluting Stents (DES) Products Offered
11.3.5 B.Braun Melsengen AG Recent Development
11.4 Biosensors
11.4.1 Biosensors Company Details
11.4.2 Company Business Overview
11.4.3 Biosensors Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Biosensors Drug Eluting Stents (DES) Products Offered
11.4.5 Biosensors Recent Development
11.5 Biotronik
11.5.1 Biotronik Company Details
11.5.2 Company Business Overview
11.5.3 Biotronik Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Biotronik Drug Eluting Stents (DES) Products Offered
11.5.5 Biotronik Recent Development
11.6 Blue Medical
11.6.1 Blue Medical Company Details
11.6.2 Company Business Overview
11.6.3 Blue Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Blue Medical Drug Eluting Stents (DES) Products Offered
11.6.5 Blue Medical Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Company Business Overview
11.7.3 Boston Scientific Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Boston Scientific Drug Eluting Stents (DES) Products Offered
11.7.5 Boston Scientific Recent Development
11.8 DISA Vascular
11.8.1 DISA Vascular Company Details
11.8.2 Company Business Overview
11.8.3 DISA Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 DISA Vascular Drug Eluting Stents (DES) Products Offered
11.8.5 DISA Vascular Recent Development
11.9 Essen
11.9.1 Essen Company Details
11.9.2 Company Business Overview
11.9.3 Essen Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Essen Drug Eluting Stents (DES) Products Offered
11.9.5 Essen Recent Development
11.10 Medtronic Vascular
11.10.1 Medtronic Vascular Company Details
11.10.2 Company Business Overview
11.10.3 Medtronic Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Medtronic Vascular Drug Eluting Stents (DES) Products Offered
11.10.5 Medtronic Vascular Recent Development
11.11 MicroPort Medical
11.12 MIV Therapeutics
11.13 Orbusneich
11.14 Promed Medical
11.15 Relisys Medical
11.16 Reva Medical
11.17 Sahajanand
11.18 Sino Medical
11.19 Sorin
11.20 Terumo Medical

12 Future Forecast
12.1 Drug Eluting Stents (DES) Market Forecast by Regions
12.1.1 Global Drug Eluting Stents (DES) Sales Forecast by Regions 2019-2025
12.1.2 Global Drug Eluting Stents (DES) Revenue Forecast by Regions 2019-2025
12.2 Drug Eluting Stents (DES) Market Forecast by Product
12.2.1 Global Drug Eluting Stents (DES) Sales Forecast by Product 2019-2025
12.2.2 Global Drug Eluting Stents (DES) Revenue Forecast by Product 2019-2025
12.3 Drug Eluting Stents (DES) Market Forecast by End User
12.4 North America Drug Eluting Stents (DES) Forecast
12.5 Europe Drug Eluting Stents (DES) Forecast
12.6 Asia Pacific Drug Eluting Stents (DES) Forecast
12.7 Central & South America Drug Eluting Stents (DES) Forecast
12.8 Middle East and Africa Drug Eluting Stents (DES) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug Eluting Stents (DES) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


List of Tables and Figures

Figure Drug Eluting Stents (DES) Product Picture
Table Drug Eluting Stents (DES) Market Segments
Table Key Manufacturers Drug Eluting Stents (DES) Covered
Table Global Drug Eluting Stents (DES) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Drug Eluting Stents (DES) Sales Market Share by Product 2014-2025
Figure Cobalt-chromium alloy Stents Product Picture
Table Major Manufacturers of Cobalt-chromium alloy Stents
Figure Magnesium alloy Stents Product Picture
Table Major Manufacturers of Magnesium alloy Stents
Figure Tyrosine polycarbonate Stents Product Picture
Table Major Manufacturers of Tyrosine polycarbonate Stents
Figure Nitinol Stents Product Picture
Table Major Manufacturers of Nitinol Stents
Figure Platinum chromium alloy Stents Product Picture
Table Major Manufacturers of Platinum chromium alloy Stents
Figure Stainless steel Stents Product Picture
Table Major Manufacturers of Stainless steel Stents
Figure Other Materials Product Picture
Table Major Manufacturers of Other Materials
Table Global Drug Eluting Stents (DES) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Coronary Heart Disease
Figure Clinical
Figure Drug Eluting Stents (DES) Report Years Considered
Figure Global Drug Eluting Stents (DES) Market Size 2014-2025 (Million US$)
Figure Global Drug Eluting Stents (DES) Sales 2014-2025 (K Units)
Table Global Drug Eluting Stents (DES) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Drug Eluting Stents (DES) Sales by Regions 2014-2019 (K Units)
Table Global Drug Eluting Stents (DES) Sales Market Share by Regions 2014-2019
Figure Global Drug Eluting Stents (DES) Sales Market Share by Regions 2014-2019
Figure 2018 Global Drug Eluting Stents (DES) Sales Market Share by Regions
Table Global Drug Eluting Stents (DES) Revenue by Regions 2014-2019 (Million US$)
Table Global Drug Eluting Stents (DES) Revenue Market Share by Regions 2014-2019
Figure Global Drug Eluting Stents (DES) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Drug Eluting Stents (DES) Revenue Market Share by Regions
Table Global Drug Eluting Stents (DES) Sales by Manufacturers (2014-2019) (K Units)
Table Global Drug Eluting Stents (DES) Sales Share by Manufacturers (2014-2019)
Figure Global Drug Eluting Stents (DES) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Drug Eluting Stents (DES) Revenue by Manufacturers (2014-2019) (Million USD)
Table Drug Eluting Stents (DES) Revenue Share by Manufacturers (2014-2019)
Figure Drug Eluting Stents (DES) Value Share by Manufacturers in 2018
Table Key Manufacturers Drug Eluting Stents (DES) Price (2014-2019) (USD/Unit)
Table Drug Eluting Stents (DES) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drug Eluting Stents (DES) Product Type
Table Date of International Manufacturers Enter into Drug Eluting Stents (DES) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drug Eluting Stents (DES) Sales by Product (2014-2019) (K Units)
Table Global Drug Eluting Stents (DES) Sales Share by Product (2014-2019)
Figure Global Drug Eluting Stents (DES) Sales Market Share by Product (2014-2019)
Figure Global Drug Eluting Stents (DES) Sales Market Share by Product in 2018
Table Global Drug Eluting Stents (DES) Revenue by Product (2014-2019) (Million US$)
Table Global Drug Eluting Stents (DES) Revenue Share by Product (2014-2019)
Figure Global Drug Eluting Stents (DES) Revenue Market Share by Product (2014-2019)
Figure Global Drug Eluting Stents (DES) Revenue Market Share by Product in 2018
Table Drug Eluting Stents (DES) Price by Product 2014-2019 (USD/Unit)
Table Global Drug Eluting Stents (DES) Sales by End User (2014-2019) (K Units)
Table Global Drug Eluting Stents (DES) Sales Share by End User (2014-2019)
Figure Global Sales Drug Eluting Stents (DES) Market Share by End User (2014-2019)
Figure Global Sales Drug Eluting Stents (DES) Market Share by End User in 2018
Figure North America Drug Eluting Stents (DES) Sales Growth Rate 2014-2019 (K Units)
Figure North America Drug Eluting Stents (DES) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Drug Eluting Stents (DES) Sales by Countries (2014-2019) (K Units)
Table North America Drug Eluting Stents (DES) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Drug Eluting Stents (DES) Sales Market Share by Countries
Table North America Drug Eluting Stents (DES) Revenue by Countries (2014-2019) (Million US$)
Table North America Drug Eluting Stents (DES) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Drug Eluting Stents (DES) Revenue Market Share by Countries
Figure United States Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure United States Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Drug Eluting Stents (DES) Sales by Product (2014-2019) (K Units)
Table North America Drug Eluting Stents (DES) Sales Market Share by Product (2014-2019)
Figure 2018 North America Drug Eluting Stents (DES) Market Share by Product
Table North America Drug Eluting Stents (DES) Sales by End User (2014-2019) (K Units)
Table North America Drug Eluting Stents (DES) Sales Market Share by End User (2014-2019)
Figure 2018 North America Drug Eluting Stents (DES) Market Share by End User
Figure Europe Drug Eluting Stents (DES) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Drug Eluting Stents (DES) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Drug Eluting Stents (DES) Sales by Countries (2014-2019) (K Units)
Table Europe Drug Eluting Stents (DES) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Drug Eluting Stents (DES) Sales Market Share by Countries
Table Europe Drug Eluting Stents (DES) Revenue by Countries (2014-2019) (Million US$)
Table Europe Drug Eluting Stents (DES) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Drug Eluting Stents (DES) Revenue Market Share by Countries
Figure Germany Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure France Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure UK Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Drug Eluting Stents (DES) Sales by Product (2014-2019) (K Units)
Table Europe Drug Eluting Stents (DES) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Drug Eluting Stents (DES) Market Share by Product
Table Europe Drug Eluting Stents (DES) Sales by End User (2014-2019) (K Units)
Table Europe Drug Eluting Stents (DES) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Drug Eluting Stents (DES) Market Share by End User
Figure Asia Pacific Drug Eluting Stents (DES) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Drug Eluting Stents (DES) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Drug Eluting Stents (DES) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Countries
Table Asia Pacific Drug Eluting Stents (DES) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Drug Eluting Stents (DES) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drug Eluting Stents (DES) Revenue Market Share by Countries
Figure China Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure China Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure India Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Drug Eluting Stents (DES) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Drug Eluting Stents (DES) Market Share by Product
Table Asia Pacific Drug Eluting Stents (DES) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Drug Eluting Stents (DES) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Drug Eluting Stents (DES) Market Share by End User
Figure Central & South America Drug Eluting Stents (DES) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Drug Eluting Stents (DES) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Drug Eluting Stents (DES) Sales by Countries (2014-2019) (K Units)
Table Central & South America Drug Eluting Stents (DES) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drug Eluting Stents (DES) Sales Market Share by Countries
Table Central & South America Drug Eluting Stents (DES) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Drug Eluting Stents (DES) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drug Eluting Stents (DES) Revenue Market Share by Countries
Figure Brazil Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Drug Eluting Stents (DES) Sales by Product (2014-2019) (K Units)
Table Central & South America Drug Eluting Stents (DES) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Drug Eluting Stents (DES) Market Share by Product
Table Central & South America Drug Eluting Stents (DES) Sales by End User (2014-2019) (K Units)
Table Central & South America Drug Eluting Stents (DES) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Drug Eluting Stents (DES) Market Share by End User
Figure Middle East and Africa Drug Eluting Stents (DES) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Drug Eluting Stents (DES) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Drug Eluting Stents (DES) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Countries
Table Middle East and Africa Drug Eluting Stents (DES) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drug Eluting Stents (DES) Revenue Market Share by Countries
Figure GCC Countries Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Drug Eluting Stents (DES) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Drug Eluting Stents (DES) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Drug Eluting Stents (DES) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Drug Eluting Stents (DES) Market Share by Product
Table Middle East and Africa Drug Eluting Stents (DES) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Drug Eluting Stents (DES) Market Share by End User
Table Abbott Vascular Company Details
Table Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Vascular Recent Development

Table Advantec Vascular Company Details
Table Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Advantec Vascular Recent Development

Table B.Braun Melsengen AG Company Details
Table B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table B.Braun Melsengen AG Recent Development

Table Biosensors Company Details
Table Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biosensors Recent Development

Table Biotronik Company Details
Table Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biotronik Recent Development

Table Blue Medical Company Details
Table Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Blue Medical Recent Development

Table Boston Scientific Company Details
Table Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boston Scientific Recent Development

Table DISA Vascular Company Details
Table DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table DISA Vascular Recent Development

Table Essen Company Details
Table Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Essen Recent Development

Table Medtronic Vascular Company Details
Table Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medtronic Vascular Recent Development

Table MicroPort Medical Company Details
Table MIV Therapeutics Company Details
Table Orbusneich Company Details
Table Promed Medical Company Details
Table Relisys Medical Company Details
Table Reva Medical Company Details
Table Sahajanand Company Details
Table Sino Medical Company Details
Table Sorin Company Details
Table Terumo Medical Company Details
Table Global Drug Eluting Stents (DES) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Drug Eluting Stents (DES) Sales Market Share Forecast by Regions 2019-2025
Table Global Drug Eluting Stents (DES) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Drug Eluting Stents (DES) Revenue Market Share Forecast by Regions 2019-2025
Table Global Drug Eluting Stents (DES) Sales Forecast by Product 2019-2025 (K Units)
Table Global Drug Eluting Stents (DES) Sales Market Share Forecast by Product 2019-2025
Table Global Drug Eluting Stents (DES) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Drug Eluting Stents (DES) Revenue Market Share Forecast by Product 2019-2025
Table Global Drug Eluting Stents (DES) Sales Forecast by End User 2019-2025 (K Units)
Table Global Drug Eluting Stents (DES) Sales Market Share Forecast by End User 2019-2025
Figure North America Drug Eluting Stents (DES) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Drug Eluting Stents (DES) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Drug Eluting Stents (DES) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Drug Eluting Stents (DES) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Drug Eluting Stents (DES) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Drug Eluting Stents (DES) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Drug Eluting Stents (DES) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Drug Eluting Stents (DES) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Drug Eluting Stents (DES) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Drug Eluting Stents (DES) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Drug Eluting Stents (DES) Value Chain
Table Drug Eluting Stents (DES) Customers List
Table Drug Eluting Stents (DES) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?
Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Request for customization
Report Snapshot
Free Sample Report

"Find new revenue generation opportunities"